# Zymofix

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/zymofix

- Industry: Biotechnology
- Headquarters: Deinze, Belgium
- Website: www.zymofix.com/
- Total disclosed funding: $1.3M
- Latest round: Seed (Aug 29, 2024)
- Investors on record: 4

## About

Founded in 2022 and based in Deinze, Belgium, by co-founders Emile Redant and Guy De Clercq, Zymofix produces microorganisms for agricultural and technical applications, transforming agricultural waste into eco-friendly microbial products. Zymofix raised an undisclosed amount of series A funding led by First Imagine!, with participation from VP Capital, High-Tech Gründerfonds, and Nest Family Office.

Zymofix offers a range of microorganisms, including bacteria, yeasts, and fungi, in concentrations suitable for industrial applications. These microbial products are formulated to support agricultural practices by enhancing soil and plant health, as well as technical application. The company use a proprietary manufacturing process that ferments biomass residues sourced from livestock farmers and industrial partners. This technology transforms agricultural waste into sterile substrates that support microbial growth. 

The company will use the funding to support the development of its new flagship production facility in Deinze and expand industrial manufacturing capacity for beneficial microorganisms.

## Funding rounds

- Seed, Aug 29, 2024, $1.3M — High-Tech Gruenderfonds, VP Capital, Nest Family Office
- Series A, date not disclosed — High-Tech Gruenderfonds, First Imagine!, VP Capital, Nest Family Office

## Investors

- High-Tech Gruenderfonds (https://capitalatlas.ai/funds/high-tech-gruenderfonds) — Series A, Seed
- First Imagine! (https://capitalatlas.ai/funds/first-imagine) — Series A
- VP Capital (https://capitalatlas.ai/funds/vp-capital) — Series A, Seed
- Nest Family Office — Series A, Seed